RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 111 filers reported holding RECRO PHARMA INC in Q4 2019. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $266,000 | -63.0% | 24,051 | -66.0% | 0.03% | -32.0% |
| Q2 2019 | $719,000 | +215.4% | 70,700 | +81.6% | 0.05% | +354.5% |
| Q1 2019 | $228,000 | -24.5% | 38,925 | -8.6% | 0.01% | -35.3% |
| Q3 2018 | $302,000 | -49.1% | 42,600 | -64.0% | 0.02% | -51.4% |
| Q2 2018 | $593,000 | +111.0% | 118,200 | +270.5% | 0.04% | +52.2% |
| Q3 2016 | $281,000 | -9.1% | 31,900 | -18.0% | 0.02% | -20.7% |
| Q2 2016 | $309,000 | -21.6% | 38,900 | -41.1% | 0.03% | -27.5% |
| Q1 2016 | $394,000 | -35.4% | 66,094 | -2.5% | 0.04% | -48.7% |
| Q4 2015 | $610,000 | +6.8% | 67,800 | +42.4% | 0.08% | +5.4% |
| Q3 2015 | $571,000 | +151.5% | 47,600 | +170.5% | 0.07% | +131.2% |
| Q2 2015 | $227,000 | – | 17,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |